X4 Pharmaceuticals, Inc (XFOR)
Biological Products, (No Diagnostic Substances)
Latest Price
$3.98
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.33
P/B Ratio
2.98
Institutional Ownership
94.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MORGAN STANLEY | 9.47M | $39.0M | 10.04% | +1.26M | 2026-03-31 |
| Empery Asset Management, LP | 8.94M | $36.0M | 9.48% | -7.0K | 2026-03-31 |
| FMR LLC | 8.10M | $33.0M | 8.59% | -395.7K | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | 7.97M | $32.0M | 8.45% | -- | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 6.74M | $27.0M | 7.14% | +423.2K | 2026-03-31 |
| Saturn V Capital Management LP | 6.46M | $26.0M | 6.85% | +656.1K | 2026-03-31 |
| Deep Track Capital, LP | 6.34M | $26.0M | 6.72% | +1.33M | 2026-03-31 |
| Kalehua Capital Management LLC | 3.72M | $15.0M | 3.95% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.50M | $14.0M | 3.71% | -- | 2026-03-31 |
| BRAIDWELL LP | 3.27M | $13.0M | 3.47% | -96.0K | 2026-03-31 |